US EditionPublished • loading... • Updated
Mytos Launches Automated CDMO for Scalable, Low-Cost Manufacturing of Stem-Cell Derived Therapies
Summary by Mid Florida Newspapers
2 Articles
2 Articles
Cell therapy CDMO Mytos unveils its first facility in the UK
UK-headquartered cell therapy manufacturer Mytos is launching its first CDMO facility in the country, with plans to establish another facility elsewhere in the next four years. “What's great about automated manufacturing is that it's very ...
Coverage Details
Total News Sources2
Leaning Left0Leaning Right0Center1Last UpdatedBias Distribution100% Center
Bias Distribution
- 100% of the sources are Center
100% Center
C 100%
Factuality
To view factuality data please Upgrade to Premium
